oral glp-1 agonist approved Not an April fool's prank! The small molecule receptor agonist, orforglipron, has been by the FDA under the trade name, "Foundayo." We discussed the data in a fall 2025 episode Oral GLP-1-Based Therapeutics in the
Pay in 4 interest-free payments of $5.48 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3





















